Exablate 2100/2100 VI System

Ablation System, High Intensity Focused Ultrasound (hifu), Mr-guided

FDA Premarket Approval P110039 S008

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for 1) software maintenance update to the currently approved clinical software (sw) versions 6. 24 (windows-xp)/6. 241 (windows-7) used in the exablate model 2100/ 2100v1 type 1. 1 / type 1. 11 system (referred to as exablate bone or the system). The new software revision will be version 6. 57 (windows-xp)/6. 58 (windows-7) (6. 57 is a set of enhancements to the sw; 6. 58 is an update to windows 7 os compatibility); and 2) addition of a water bag as an accessory for acoustic coupling. The water bag will be provided as an optional accessory to be used as an alternative to the previously-approved gel pad.

DeviceExablate 2100/2100 VI System
Classification NameAblation System, High Intensity Focused Ultrasound (hifu), Mr-guided
Generic NameAblation System, High Intensity Focused Ultrasound (hifu), Mr-guided
ApplicantInSightec
Date Received2017-09-22
Decision Date2018-01-25
PMAP110039
SupplementS008
Product CodeNRZ
Docket NumberPremarket Approval (PMA) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Links U.S. Food & Drug Administration   Follow FDA En Español Search FDA   Home Food Drugs Medical Devices Radia
Advisory CommitteeGeneral & Plastic Surgery
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address InSightec 5 Nahum Heth Street tirat-carmel 39120

Supplemental Filings

Supplement NumberDateSupplement Type
P110039Original Filing
S010 2018-04-26 Real-time Process
S009
S008 2017-09-22 Normal 180 Day Track
S007
S006 2016-05-10 Real-time Process
S005 2016-04-04 Real-time Process
S004 2013-09-23 Real-time Process
S003 2013-06-28 Normal 180 Day Track No User Fee
S002 2012-11-06 Normal 180 Day Track No User Fee
S001 2012-11-06 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.